(Q34292419)

1 August 2017

1 reference

title

The importance of first-phase insulin secretion: implications for the therapy of type 2 diabetes mellitus (English)

1 reference

1 August 2017

0 references

1 reference

Del Prato S

1

1 reference

1 August 2017

Tiengo A

series ordinal

2

1 reference

1 August 2017

publication date

1 May 2001

1 reference

Diabetes - Metabolism: Research and Reviews

1 August 2017

published in

1 reference

1 August 2017

volume

17

1 reference

1 August 2017

issue

3

1 reference

1 August 2017

page(s)

164-174

1 reference

Pathogenesis of NIDDM. A balanced overview

1 August 2017

cites work

1 reference

Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus

21 January 2018

1 reference

Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus

21 January 2018

1 reference

Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians.

21 January 2018

1 reference

Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus.

21 January 2018

1 reference

The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents

21 January 2018

1 reference

Loss of the first phase insulin response to intravenous glucose in subjects with persistent impaired glucose tolerance.

21 January 2018

1 reference

Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM. Evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative.

21 January 2018

1 reference

The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus

21 January 2018

1 reference

Cephalic phase metabolic responses in normal weight adults

21 January 2018

1 reference

Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance.

21 January 2018

1 reference

Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM.

21 January 2018

1 reference

Effects of a change in the pattern of insulin delivery on carbohydrate tolerance in diabetic and nondiabetic humans in the presence of differing degrees of insulin resistance

21 January 2018

1 reference

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

21 January 2018

1 reference

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes.

21 January 2018

1 reference

Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study

21 January 2018

1 reference

The emerging role of post-prandial hyperglycaemic spikes in the pathogenesis of diabetic complications

21 January 2018

1 reference

Oxygen reactivity in diabetes mellitus: effect of hypertension and hyperglycaemia

21 January 2018

1 reference

Effect of strict glycemic control on renal hemodynamic response to amino acids and renal enlargement in insulin-dependent diabetes mellitus.

21 January 2018

1 reference

Reduced fibrinogen survival in diabetes mellitus. A reversible phenomenon

21 January 2018

1 reference

Blood glucose may condition factor VII levels in diabetic and normal subjects.

21 January 2018

1 reference

Endothelium-dependent vasodilatation is impaired in both microcirculation and macrocirculation during acute hyperglycemia.

21 January 2018

1 reference

Vascular effects of acute hyperglycemia in humans are reversed by L-arginine. Evidence for reduced availability of nitric oxide during hyperglycemia

21 January 2018

1 reference

New insights on non-enzymatic glycosylation may lead to therapeutic approaches for the prevention of diabetic complications

21 January 2018

1 reference

Oxidative stress and diabetic vascular complications

21 January 2018

1 reference

Diabetes, asymptomatic hyperglycemia, and 22-year mortality in black and white men. The Chicago Heart Association Detection Project in Industry Study

21 January 2018

1 reference

Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria

21 January 2018

1 reference

Cardiovascular disease in older adults with glucose disorders: comparison of American Diabetes Association criteria for diabetes mellitus with WHO criteria.

21 January 2018

1 reference

Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up

21 January 2018

1 reference

Significance of testing platelet functions in vitro

21 January 2018

1 reference

A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44)

21 January 2018

1 reference

Pramlintide, a synthetic analog of human amylin, improves the metabolic profile of patients with type 2 diabetes using insulin. The Pramlintide in Type 2 Diabetes Group

21 January 2018

1 reference

Inhibition by etomoxir of carnitine palmitoyltransferase I reduces hepatic glucose production and plasma lipids in non-insulin-dependent diabetes mellitus.

21 January 2018

1 reference

21 January 2018

1 reference

Stimulation of insulin release by non-sulfonylurea hypoglycemic agents: the meglitinide family

21 January 2018

1 reference

Effects of a new oral hypoglycaemic agent, repaglinide, on metabolic control in sulphonylurea-treated patients with NIDDM.

21 January 2018

1 reference

A 1-year multicenter randomized double-blind comparison of repaglinide and glyburide for the treatment of type 2 diabetes. Dutch and German Repaglinide Study Group.

21 January 2018

1 reference

21 January 2018

1 reference

Induction of insulin resistance by glucosamine reduces blood flow but not interstitial levels of either glucose or insulin.

21 January 2018

1 reference

Rapid and short-acting mealtime insulin secretion with nateglinide controls both prandial and mean glycemia.

21 January 2018

1 reference

Influence of hyperinsulinemia, hyperglycemia, and the route of glucose administration on splanchnic glucose exchange

21 January 2018

1 reference

Is glucagon-like peptide 1 an incretin hormone?

21 January 2018

1 reference

Insulinotropic action of glucagonlike peptide-I-(7-37) in diabetic and nondiabetic subjects

21 January 2018

1 reference

Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients.

21 January 2018

1 reference

Dipeptidyl peptidase IV inhibition potentiates the insulinotropic effect of glucagon-like peptide 1 in the anesthetized pig.

21 January 2018

1 reference

Glucose-lowering and insulin-sensitizing actions of exendin-4: studies in obese diabetic (ob/ob, db/db) mice, diabetic fatty Zucker rats, and diabetic rhesus monkeys (Macaca mulatta).

21 January 2018

1 reference

Monomeric insulins and their experimental and clinical implications

21 January 2018

1 reference

Insulin-dependent regulation of insulin receptor concentrations: a direct demonstration in cell culture.

21 January 2018

1 reference

Intensive conventional insulin therapy for type II diabetes. Metabolic effects during a 6-mo outpatient trial

21 January 2018

1 reference

Banting lecture 1988. Role of insulin resistance in human disease

21 January 2018

1 reference

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

21 January 2018

1 reference

1,5-Anhydro-D-glucitol Evaluates Daily Glycemic Excursions in Well-Controlled NIDDM

21 January 2018

1 reference

The amylin analog pramlintide improves glycemic control and reduces postprandial glucagon concentrations in patients with type 1 diabetes mellitus

21 January 2018

1 reference

Inhibition of the activity of dipeptidyl-peptidase IV as a treatment for type 2 diabetes

21 January 2018

1 reference

Hyperglycemia may determine fibrinopeptide A plasma level increase in humans

21 January 2018

1 reference

Post-meal coagulation activation in diabetes mellitus: the effect of acarbose

21 January 2018

1 reference

Hyperglycemia-Induced Thrombin Formation in Diabetes: The Possible Role of Oxidative Stress

21 January 2018

1 reference

Insulin regulation of glucose and lipid metabolism in massive obesity

21 January 2018

1 reference

7 January 2021

1 reference

7 January 2021

The relative importance of first- and second-phase insulin secretion in countering the action of glucagon on glucose turnover in the conscious dog

1 reference

7 January 2021

Relative importance of first- and second-phase insulin secretion in glucose homeostasis in conscious dog. II. Effects on gluconeogenesis

1 reference

7 January 2021

Structure of cat islet amyloid polypeptide and identification of amino acid residues of potential significance for islet amyloid formation

1 reference

7 January 2021

Nerve conduction velocity in man: influence of glucose, somatostatin and electrolytes

1 reference

7 January 2021

Hyperglycemia affects cardiovascular autonomic nerve function in normal subjects

1 reference

7 January 2021

Activation of human platelet protein kinase C-beta 2 in vivo in response to acute hyperglycemia

1 reference

7 January 2021

Hyperglycemia-induced circulating ICAM-1 increase in diabetes mellitus: the possible role of oxidative stress

1 reference

7 January 2021

Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo

1 reference

7 January 2021

Role of oxidative stress in diabetic complications: a new perspective on an old paradigm

1 reference

7 January 2021

The effect of acute hyperglycaemia on QTc duration in healthy man

1 reference

7 January 2021

Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry. Honolulu Heart Program

1 reference

7 January 2021

Effects of oral hypoglycemic agent methylpalmoxirate on exercise capacity of streptozocin diabetic rats

1 reference

7 January 2021

Gliclazide potentiates suppression of hepatic glucose production in non—insulin-dependent diabetic patients

1 reference

7 January 2021

Effects of tolazamide and exogenous insulin on insulin action in patients with non-insulin-dependent diabetes mellitus

1 reference

7 January 2021

Mealtime glucose regulation by nateglinide in type-2 diabetes mellitus

1 reference

7 January 2021

The disposal of an oral glucose load in patients with non-insulin-dependent diabetes

1 reference

7 January 2021

Importance of Timing of Preprandial Subcutaneous Insulin Administration in the Management of Diabetes Mellitus

1 reference

7 January 2021

Physiological importance of deficiency in early prandial insulin secretion in non-insulin-dependent diabetes

1 reference

7 January 2021

Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients

1 reference

7 January 2021

Effect of sustained physiologic hyperinsulinaemia and hyperglycaemia on insulin secretion and insulin sensitivity in man

1 reference

7 January 2021

Characteristics of glycemic stability

1 reference

7 January 2021

Identifiers

DOI

10.1002/DMRR.198

1 reference

1 August 2017

1 reference